We are live on ! Find out more

419 hedge funds and large institutions have $5.98B invested in Chemed in 2022 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 144 increasing their positions, 167 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

557% more call options, than puts

Call options by funds: $5.19M | Put options by funds: $791K

34% more capital inflows, than outflows

Capital inflows: $381M | Capital outflows: $284M

1.34% more ownership

Funds ownership: 90.09% → 91.43% (+1.3%)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

2% less funds holding

Funds holding: 429 → 419 (-10)

14% less repeat investments, than reductions

Existing positions increased: 144 | Existing positions reduced: 167

22% less first-time investments, than exits

New positions opened: 32 | Existing positions closed: 41

Holders
419
Holders Change
-10
Holders Change %
-2.33%
% of All Funds
7.18%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
32
Increased
144
Reduced
167
Closed
41
Calls
$5.19​M
Puts
$791​K
Net Calls
+$4.4​M
Net Calls Change
+$1.45​M

CHE Hedge Fund Activity: Q3 2022 in Review

419 of the 5,833 institutional investors tracked by Wall St. Rank reported a position in Chemed (CHE) for Q3 2022, worth a combined $5.98B — down 5.7% from $6.35B a quarter earlier.

Sellers outnumbered buyers: 41 funds closed out of CHE and 32 opened new positions — a net loss of 9 holders — while 167 trimmed existing stakes and 144 added.

The largest buyer was Vaughan Nelson Investment Management, opening a new position worth an estimated $83.3M. The largest seller was Janus Henderson Group, cutting an estimated $42M.

  • 419 institutional investors held Chemed (CHE) as of Q3 2022, down from 429 in Q2 2022.
  • Funds reported $5.98B of Chemed stock for Q3 2022, down 5.7% quarter-over-quarter.
  • 32 funds opened new Chemed positions in Q3 2022 and 41 closed out, a net change of -9 holders.
  • The largest Chemed buyer in Q3 2022 was Vaughan Nelson Investment Management, an estimated $83.3M added.
  • The largest Chemed seller in Q3 2022 was Janus Henderson Group, an estimated $42M sold.

Based on aggregated 13F filings for Q3 2022.